{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:59:14Z","timestamp":1795089554290,"version":"4.10.2"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"S1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:p>Studies in the 1920s found that botulinum neurotoxin type A (BoNT\/A) inhibited the activity of motor and parasympathetic nerve endings, confirmed several decades later to be due to decreased acetylcholine release. The 1970s were marked by studies of cellular mechanisms aided by use of neutralizing antibodies as pharmacologic tools: BoNT\/A disappeared from accessibility to neutralizing antibodies within minutes, although it took several hours for onset of muscle weakness. The multi-step mechanism was experimentally confirmed and is now recognized to consist broadly of binding to nerve terminals, internalization, and lysis or cleavage of a protein (SNAP-25: synaptosomal associated protein-25\u2009kDa) that is part of the SNARE (Soluble NSF Attachment protein REceptor) complex needed for synaptic vesicle docking and fusion. Clinical use of the BoNT\/A product onabotulinumtoxinA was based on its ability to reduce muscle contractions via inhibition of acetylcholine from motor terminals. Sensory mechanisms of onabotulinumtoxinA have now been identified, supporting its successful treatment of chronic migraine and urgency in overactive bladder. Exploration into migraine mechanisms led to anatomical studies documenting pain fibers that send axons through sutures of the skull to outside the head\u2014a potential route by which extracranial injections could affect intracranial processes. Several clinical studies have also identified benefits of onabotulinumtoxinA in major depression, which have been attributed to central responses induced by feedback from facial muscle and skin movement. Overall, the history of BoNT\/A is distinguished by basic science studies that stimulated clinical use and, conversely, clinical observations that spurred basic research into novel mechanisms of action.<\/jats:p>","DOI":"10.1097\/md.0000000000032372","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T19:00:24Z","timestamp":1690484424000},"page":"e32372","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":66,"title":["Botox (onabotulinumtoxinA) mechanism of action"],"prefix":"10.1097","volume":"102","author":[{"given":"Mitchell F.","family":"Brin","sequence":"first","affiliation":[{"name":"Allergan\/AbbVie, Irvine, CA, USA"},{"name":"University of California, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Burstein","sequence":"additional","affiliation":[{"name":"Departments of Anesthesia and Neuroscience, Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20240803","first-page":"1","article-title":"Uber einen neuen anaeroben Bacillus und seine Beziehung zum Botulismus.","volume":"26","author":"Van Ermengem","year":"1897","journal-title":"Z Hyg Infektionskrankh"},{"key":"R3-20240803","first-page":"335","article-title":"Essai d\u2019immunisation par la voie gastrointestinale contre la toxine botulique [letter].","volume":"24","author":"Tchitchikine","year":"1905","journal-title":"Ann Inst Pasteur XIX"},{"key":"R4-20240803","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.38.4.327","article-title":"Botulism. Studies on the manner in which the toxin of clostridium botulinum acts upon the body: II. The effect upon the voluntary nervous system.","volume":"38","author":"Dickson","year":"1923","journal-title":"J Exp Med"},{"key":"R5-20240803","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.37.5.711","article-title":"Botulism. Studies on the manner in which the toxin of clostridium botulinum acts upon the body: I. The effect upon the autonomic nervous system.","volume":"37","author":"Dickson","year":"1923","journal-title":"J Exp Med"},{"key":"R6-20240803","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1954.sp005067","article-title":"The action of botulinum toxin on motor-nerve filaments.","volume":"123","author":"Brooks","year":"1954","journal-title":"J Physiol"},{"key":"R7-20240803","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","article-title":"The action of botulinum toxin on the neuro-muscular junction.","volume":"109","author":"Burgen","year":"1949","journal-title":"J Physiol"},{"key":"R8-20240803","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/infdis\/43.2.152","article-title":"Studies on botulinus toxin. 3. Acid precipitation of botulinus toxin.","volume":"43","author":"Snipe","year":"1928","journal-title":"J Infect Dis"},{"key":"R9-20240803","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jb.52.1.1-13.1946","article-title":"Botulinum toxin (type A); including a study of shaking with chloroform as a step in the isolation procedure.","volume":"52","author":"Lamanna","year":"1946","journal-title":"J Bacteriol"},{"key":"R10-20240803","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.103.2681.613","article-title":"The purification and crystallization of clostridium botulinum type A toxin.","volume":"103","author":"Lamanna","year":"1946","journal-title":"Science"},{"key":"R11-20240803","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/jb.61.6.751-752.1951","article-title":"The lack of identity between hemagglutinin and the toxin of type A botulinal organism.","volume":"61","author":"Lamanna","year":"1951","journal-title":"J Bacteriol"},{"key":"R12-20240803","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0006-291X(66)90212-9","article-title":"Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A.","volume":"22","author":"DasGupta","year":"1966","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-20240803","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/iai.6.4.587-590.1972","article-title":"Role of a protease in natural activation of Clostridium botulinum neurotoxin.","volume":"6","author":"Das Gupta","year":"1972","journal-title":"Infect Immun"},{"key":"R14-20240803","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0028-3908(71)90082-7","article-title":"Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission.","volume":"10","author":"Simpson","year":"1971","journal-title":"Neuropharmacology"},{"key":"R15-20240803","first-page":"27","article-title":"Studies on the mechanism of action of botulinum toxin.","volume":"3","author":"Simpson","year":"1979","journal-title":"Adv Cytopharmacol"},{"key":"R16-20240803","first-page":"155","article-title":"The origin, structure, and pharmacological activity of botulinum toxin.","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"key":"R17-20240803","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0006-291X(92)92305-H","article-title":"Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis.","volume":"189","author":"Link","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-20240803","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1002\/j.1460-2075.1992.tb05441.x","article-title":"Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc.","volume":"11","author":"Schiavo","year":"1992","journal-title":"EMBO J"},{"key":"R19-20240803","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"R20-20240803","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(93)80448-4","article-title":"Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds.","volume":"335","author":"Schiavo","year":"1993","journal-title":"FEBS Lett"},{"key":"R21-20240803","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1002\/j.1460-2075.1993.tb06171.x","article-title":"Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1\/syntaxin.","volume":"12","author":"Blasi","year":"1993","journal-title":"EMBO J"},{"key":"R22-20240803","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1002\/j.1460-2075.1994.tb06834.x","article-title":"Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly.","volume":"13","author":"Hayashi","year":"1994","journal-title":"EMBO J"},{"key":"R23-20240803","doi-asserted-by":"crossref","first-page":"18349","DOI":"10.1073\/pnas.1319309110","article-title":"Profile of Thomas Sudhof, James Rothman, and Randy Schekman, 2013 Nobel laureates in physiology or medicine.","volume":"110","author":"Wickner","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R24-20240803","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1471-4159.1971.tb03750.x","article-title":"The binding of botulinum toxin to membrane lipids: sphingolipids, steroids and fatty acids.","volume":"18","author":"Simpson","year":"1971","journal-title":"J Neurochem"},{"key":"R25-20240803","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0304-4165(80)90382-7","article-title":"Interaction between Clostridium botulinum neurotoxin and gangliosides.","volume":"628","author":"Kitamura","year":"1980","journal-title":"Biochim Biophys Acta"},{"key":"R26-20240803","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxicon.2020.02.006","article-title":"Neuronal selectivity of botulinum neurotoxins.","volume":"178","author":"Poulain","year":"2020","journal-title":"Toxicon"},{"key":"R27-20240803","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1016\/S0021-9258(17)34087-5","article-title":"Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.","volume":"269","author":"Nishiki","year":"1994","journal-title":"J Biol Chem"},{"key":"R28-20240803","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A.","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"R29-20240803","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.","volume":"580","author":"Mahrhold","year":"2006","journal-title":"FEBS Lett"},{"key":"R30-20240803","doi-asserted-by":"crossref","first-page":"e1003369","DOI":"10.1371\/journal.ppat.1003369","article-title":"Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT\/A).","volume":"9","author":"Jacky","year":"2013","journal-title":"PLoS Pathog"},{"key":"R31-20240803","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1038\/s41598-021-87331-7","article-title":"Characterization of clostridium botulinum neurotoxin serotype A (BoNT\/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay.","volume":"11","author":"James","year":"2021","journal-title":"Sci Rep"},{"key":"R32-20240803","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneur.1986.00520040060020","article-title":"Botulinum toxin in the management of blepharospasm.","volume":"43","author":"Dutton","year":"1986","journal-title":"Arch Neurol"},{"key":"R33-20240803","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/WNL.41.11.1800","article-title":"Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm.","volume":"41","author":"Alderson","year":"1991","journal-title":"Neurology"},{"key":"R34-20240803","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.","volume":"96","author":"de Paiva","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 8","key":"R35-20240803","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/mds.20006","article-title":"Is the light chain subcellular localization an important factor in botulinum toxin duration of action?","volume":"19","author":"Fernandez-Salas","year":"2004","journal-title":"Mov Disord"},{"key":"R36-20240803","doi-asserted-by":"crossref","first-page":"E5158","DOI":"10.1073\/pnas.1621076114","article-title":"Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication.","volume":"114","author":"Tsai","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 15","key":"R37-20240803","first-page":"3294","article-title":"Recruitment of septin cytoskeletal proteins by botulinum toxin A protease determines its remarkable stability.","volume":"127","author":"Vagin","year":"2014","journal-title":"J Cell Sci"},{"issue":"suppl 8","key":"R38-20240803","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.20003","article-title":"Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin.","volume":"19","author":"Erbguth","year":"2004","journal-title":"Mov Disord"},{"key":"R39-20240803","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1951.sp004551","article-title":"A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre.","volume":"113","author":"Ambache","year":"1951","journal-title":"J Physiol"},{"key":"R40-20240803","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/00016489509139348","article-title":"Frey\u2019s syndrome: treatment with botulinum toxin.","volume":"115","author":"Drobik","year":"1995","journal-title":"Acta Otolaryngol"},{"key":"R41-20240803","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2230.1996.tb00093.x","article-title":"Botulinum toxin\u2014a possible new treatment for axillary hyperhidrosis.","volume":"21","author":"Bushara","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"R42-20240803","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archderm.139.6.731","article-title":"Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.","volume":"139","author":"Naumann","year":"2003","journal-title":"Arch Dermatol"},{"key":"R43-20240803","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"R44-20240803","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2036.1995.tb00428.x","article-title":"Review article: the use of botulinum toxin in the alimentary tract.","volume":"9","author":"Albanese","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"R45-20240803","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients.","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"R46-20240803","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.","volume":"185","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"R48-20240803","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.neuroscience.2009.09.001","article-title":"Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia.","volume":"164","author":"Hoover","year":"2009","journal-title":"Neuroscience"},{"key":"R49-20240803","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4070\/kcj.2010.40.8.387","article-title":"Short-term autonomic denervation of the atria using botulinum toxin.","volume":"40","author":"Oh","year":"2010","journal-title":"Korean Circ J"},{"key":"R50-20240803","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCEP.111.961854","article-title":"Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation.","volume":"4","author":"Oh","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R51-20240803","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.hrthm.2018.08.019","article-title":"Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study.","volume":"16","author":"Romanov","year":"2019","journal-title":"Heart Rhythm"},{"key":"R52-20240803","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.hrthm.2018.08.021","article-title":"Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.","volume":"16","author":"Waldron","year":"2019","journal-title":"Heart Rhythm"},{"issue":"Suppl 5S","key":"R53-20240803","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/j.hrthm.2023.03.558","article-title":"Efficacy of botulinum toxin type A (AGN-151607) for the prevention of postoperative atrial fibrillation in cardiac surgery patients: atrial fibrillation and anticoagulation results from the phase 2 NOVA study [Abstract PO-01-167].","volume":"20","author":"Waldron","year":"2023","journal-title":"Heart Rhythm"},{"key":"R54-20240803","article-title":"OnabotulinumtoxinA development, insights, and impact: treatment of chronic migraine.","author":"Turkel","journal-title":"Medicine (Suppl)"},{"key":"R55-20240803","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1524-4725.1998.tb04098.x","article-title":"Treatment of hyperfunctional lines of the face with botulinum toxin A.","volume":"24","author":"Binder","year":"1998","journal-title":"Dermatol Surg"},{"key":"R56-20240803","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R57-20240803","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis.","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"R58-20240803","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.","volume":"2","author":"Brin","year":"1987","journal-title":"Mov Disord"},{"key":"R59-20240803","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jnnp.58.2.232","article-title":"Treatment of chronic limb spasticity with botulinum toxin A.","volume":"58","author":"Dunne","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R60-20240803","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"},{"key":"R61-20240803","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"issue":"4 Pt 1","key":"R62-20240803","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","article-title":"Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats.","volume":"172","author":"Chuang","year":"2004","journal-title":"J Urol"},{"key":"R63-20240803","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"R64-20240803","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","article-title":"Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity.","volume":"279","author":"Morenilla-Palao","year":"2004","journal-title":"J Biol Chem"},{"key":"R65-20240803","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor.","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"R66-20240803","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of action of onabotulinumtoxinA in chronic migraine: a narrative review.","volume":"60","author":"Burstein","year":"2020","journal-title":"Headach"},{"key":"R67-20240803","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09647049209525535","article-title":"The Galenic tradition and migraine.","volume":"1","author":"Isler","year":"1992","journal-title":"J Hist Neurosci"},{"key":"R68-20240803","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pain.2006.09.012","article-title":"Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.","volume":"125","author":"Jakubowski","year":"2006","journal-title":"Pain"},{"key":"R69-20240803","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cne.22049","article-title":"Sensory innervation of the calvarial bones of the mouse.","volume":"515","author":"Kosaras","year":"2009","journal-title":"J Comp Neurol"},{"key":"R70-20240803","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.pain.2013.04.040","article-title":"Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache.","volume":"154","author":"Schueler","year":"2013","journal-title":"Pain"},{"key":"R71-20240803","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1523\/JNEUROSCI.2153-18.2018","article-title":"Non-Trigeminal Nociceptive Innervation of the Posterior Dura: Implications to Occipital Headache.","volume":"39","author":"Noseda","year":"2019","journal-title":"J Neurosci"},{"key":"R72-20240803","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0333102414527648","article-title":"Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains.","volume":"34","author":"Burstein","year":"2014","journal-title":"Cephalalgia"},{"key":"R73-20240803","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1177\/0333102419873675","article-title":"Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats.","volume":"39","author":"Melo-Carrillo","year":"2019","journal-title":"Cephalalgia"},{"key":"R74-20240803","first-page":"271","article-title":"Botulinum toxin treatment of urethral and bladder dysfunction.","volume":"56","author":"Yokoyama","year":"2002","journal-title":"Acta Med Okayama"},{"key":"R75-20240803","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","article-title":"Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury.","volume":"45","author":"Khera","year":"2004","journal-title":"Neurochem Int"},{"key":"R76-20240803","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intraetrusor injections of botulinum toxin for human detrusor overactivity.","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"R78-20240803","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpsychires.2012.01.027","article-title":"Facing depression with botulinum toxin: a randomized controlled trial.","volume":"46","author":"Wollmer","year":"2012","journal-title":"J Psychiatr Res"},{"key":"R79-20240803","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","article-title":"Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial.","volume":"52","author":"Finzi","year":"2014","journal-title":"J Psychiatr Res"},{"key":"R80-20240803","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4088\/JCP.13m08845","article-title":"Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.","volume":"75","author":"Magid","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"R81-20240803","first-page":"982","article-title":"Efficacy of Botox versus placebo for treatment of patients with major depression.","volume":"46","author":"Zamanian","year":"2017","journal-title":"Iran J Public Health"},{"key":"R82-20240803","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/YIC.0000000000000290","article-title":"OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females.","volume":"35","author":"Brin","year":"2020","journal-title":"Int Clin Psychopharmacol"},{"key":"R83-20240803","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41598-017-01590-x","article-title":"Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications.","volume":"7","author":"Cohen","year":"2017","journal-title":"Sci Rep"},{"key":"R84-20240803","doi-asserted-by":"crossref","first-page":"12851","DOI":"10.1038\/s41598-020-69773-7","article-title":"Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites.","volume":"10","author":"Makunts","year":"2020","journal-title":"Sci Rep"},{"key":"R85-20240803","first-page":"645","article-title":"Treatment of depression with botulinum toxin A: a case series.","volume":"32","author":"Finzi","year":"2006","journal-title":"Dermatol Surg"},{"key":"R88-20240803","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jnnp-2013-307316","article-title":"Alleviating manoeuvres (sensory tricks) in cervical dystonia.","volume":"85","author":"Patel","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R89-20240803","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-510X(97)00151-2","article-title":"The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site.","volume":"152","author":"Giladi","year":"1997","journal-title":"J Neurol Sci"},{"issue":"Pt 4","key":"R90-20240803","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/brain\/120.4.571","article-title":"Botulinum toxin does not reverse the cortical dysfunction associated with writer\u2019s cramp. A PET study.","volume":"120","author":"Ceballos-Baumann","year":"1997","journal-title":"Brain"},{"issue":"Pt 1","key":"R91-20240803","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/brain\/awh665","article-title":"Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia.","volume":"129","author":"Dresel","year":"2006","journal-title":"Brain"},{"key":"R92-20240803","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1552-6569.2011.00682.x","article-title":"Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a.","volume":"23","author":"Tomasova","year":"2013","journal-title":"J Neuroimaging"},{"key":"R93-20240803","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1552-6569.2009.00375.x","article-title":"Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.","volume":"20","author":"Senkarova","year":"2010","journal-title":"J Neuroimaging"},{"key":"R94-20240803","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2011.03.040","article-title":"Sensorimotor network in cervical dystonia and the effect of botulinum toxin treatment: a functional MRI study.","volume":"306","author":"Opavsky","year":"2011","journal-title":"J Neurol Sci"},{"key":"R95-20240803","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00207454.2011.623807","article-title":"Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study.","volume":"122","author":"Opavsky","year":"2012","journal-title":"Int J Neurosci"},{"key":"R96-20240803","doi-asserted-by":"crossref","first-page":"e62877","DOI":"10.1371\/journal.pone.0062877","article-title":"Task-free functional MRI in cervical dystonia reveals multi-network changes that partially normalize with botulinum toxin.","volume":"8","author":"Delnooz","year":"2013","journal-title":"PLoS One"},{"key":"R97-20240803","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12883-015-0306-4","article-title":"Cortical activation changes and improved motor function in stroke patients after focal spasticity therapy\u2014an interventional study applying repeated fMRI.","volume":"15","author":"Bergfeldt","year":"2015","journal-title":"BMC Neurol"},{"key":"R98-20240803","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00221-018-5322-3","article-title":"Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.","volume":"236","author":"Nevrly","year":"2018","journal-title":"Exp Brain Res"},{"key":"R100-20240803","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cne.903350402","article-title":"Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat.","volume":"335","author":"Burstein","year":"1993","journal-title":"J Comp Neurol"},{"key":"R101-20240803","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1152\/jn.1998.79.2.964","article-title":"Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons.","volume":"79","author":"Burstein","year":"1998","journal-title":"J Neurophysiol"},{"key":"R102-20240803","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1096-9861(19981012)400:1<125::AID-CNE9>3.0.CO;2-B","article-title":"Cells of origin of the trigeminohypothalamic tract in the rat.","volume":"400","author":"Malick","year":"1998","journal-title":"J Comp Neurol"},{"issue":"suppl 1","key":"R103-20240803","first-page":"S4410.1016","article-title":"Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain.","volume":"154","author":"Noseda","year":"2013","journal-title":"Pain"},{"key":"R104-20240803","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neubiorev.2007.12.002","article-title":"The role of the amygdala in emotional processing: a quantitative meta-analysis of functional neuroimaging studies.","volume":"32","author":"Sergerie","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"R105-20240803","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cercor\/bhn104","article-title":"The link between facial feedback and neural activity within central circuitries of emotion\u2014new insights from botulinum toxin-induced denervation of frown muscles.","volume":"19","author":"Hennenlotter","year":"2009","journal-title":"Cereb Cortex"},{"key":"R106-20240803","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2045-5380-4-11","article-title":"Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design.","volume":"4","author":"Kim","year":"2014","journal-title":"Biol Mood Anxiety Disord"},{"key":"R107-20240803","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1038\/s41598-023-29280-x","article-title":"Modulation of amygdala activity for emotional faces due to botulinum toxin type A injections that prevent frowning.","volume":"13","author":"Stark","year":"2023","journal-title":"Sci Rep"},{"key":"R108-20240803","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.neuroimage.2011.06.057","article-title":"Simultaneous acquisition of corrugator electromyography and functional magnetic resonance imaging: a new method for objectively measuring affect and neural activity concurrently.","volume":"58","author":"Heller","year":"2011","journal-title":"Neuroimage"},{"key":"R109-20240803","doi-asserted-by":"crossref","first-page":"e957e957","DOI":"10.1038\/tp.2016.130","article-title":"Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.","volume":"6","author":"Godlewska","year":"2016","journal-title":"Transl Psychiatry"},{"key":"R110-20240803","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.","volume":"46","author":"Carruthers","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R111-20240803","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.PRS.0000076504.79727.62","article-title":", Botox Glabellar Lines II Study Group. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.","volume":"112","author":"Carruthers","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R112-20240803","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamafacial.2015.0376","article-title":"Alterations in the elasticity, pliability, and viscoelastic properties of facial skin after injection of onabotulinum toxin A.","volume":"17","author":"Bonaparte","year":"2015","journal-title":"JAMA Facial Plast Surg"},{"key":"R113-20240803","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12433","article-title":"The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation.","volume":"30","author":"Zhu","year":"2017","journal-title":"Dermatol Ther"},{"key":"R114-20240803","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-4632.2008.03895.x","article-title":"The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.","volume":"47","author":"Chang","year":"2008","journal-title":"Int J Dermatol"},{"key":"R115-20240803","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jocd.12144","article-title":"The use of Botulinum toxin-a injection for facial wrinkles: a histological and immunohistochemical evaluation.","volume":"14","author":"El-Domyati","year":"2015","journal-title":"J Cosmet Dermatol"},{"key":"R116-20240803","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/j.1460-2075.1993.tb05924.x","article-title":"Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation.","volume":"12","author":"Werner","year":"1993","journal-title":"EMBO J"},{"key":"R117-20240803","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1524-4725.2012.02504.x","article-title":"The potential effect of botulinum toxin type A on human dermal fibroblasts: an in vitro study.","volume":"38","author":"Oh","year":"2012","journal-title":"Dermatol Surg"},{"issue":"suppl 3","key":"R118-20240803","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/DSS.0000000000001404","article-title":"Preventive, cumulative effects of botulinum toxin type A in facial aesthetics.","volume":"43","author":"Humphrey","year":"2017","journal-title":"Dermatol Surg"},{"key":"R119-20240803","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size.","volume":"7","author":"Shah","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"3 Pt 1","key":"R120-20240803","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/dsu.12097","article-title":"Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin.","volume":"39443","author":"Rose","year":"2013","journal-title":"Dermatol Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T01:56:48Z","timestamp":1722736608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":114,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032372","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,1]]}}}